Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study
BackgroundPatients who have recently received a hematopoietic cell transplant (HCT) are at higher risk of acute complications in the first weeks after discharge, especially during the COVID-19 pandemic. ObjectiveThe aim of this study was to test the use of a teleh...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2021-03-01
|
Series: | JMIR Formative Research |
Online Access: | https://formative.jmir.org/2021/3/e26121 |
id |
doaj-5e1c398c8b654744b736f1ad7e9eaa47 |
---|---|
record_format |
Article |
spelling |
doaj-5e1c398c8b654744b736f1ad7e9eaa472021-04-02T20:55:04ZengJMIR PublicationsJMIR Formative Research2561-326X2021-03-0153e2612110.2196/26121Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot StudyMussetti, AlbertoSalas, Maria QueraltCondom, MariaAntonio, MaiteOchoa, CristianIvan, IuliaJimenez Ruiz-De la Torre, DavidSanz Linares, GabrielaAnsoleaga, BelenPatiño-Gutierrez, BeatrizJimenez-Prat, LauraParody, RocioSureda-Balari, Ana BackgroundPatients who have recently received a hematopoietic cell transplant (HCT) are at higher risk of acute complications in the first weeks after discharge, especially during the COVID-19 pandemic. ObjectiveThe aim of this study was to test the use of a telehealth platform for the follow-up of HCT patients during the first two weeks after discharge. MethodsIn total, 21 patients who received autologous or allogeneic HCT for hematological malignancies were screened from April 30, 2020, to July 15, 2020. The telehealth platform assisted in the daily collection of vital signs as well as physical and psychological symptoms for two weeks after hospital discharge. The required medical devices (oximeter and blood pressure monitor) were given to patients and a dedicated smartphone app was developed to collect this data. The data were reviewed daily through web-based software by a hematologist specializing in HCT. ResultsOnly 12 of 21 patients were able to join and complete the study. Technological barriers were the most frequent limiting factor in this study. Among the 12 patients who completed the study, adherence to data reporting was high. The patients’ experience of using such a system was considered good. In two cases, the system enabled the early recognition of acute complications. ConclusionsThis pilot study showed that telehealth systems can be applied in the early posttransplant setting, with evident advantages for physicians and patients for both medical and psychological aspects. Technological issues still represent a challenge for the applicability of such a system, especially for older adult patients. Easier-to-use technologies could help to expand the use of telehealth systems in this setting in the future.https://formative.jmir.org/2021/3/e26121 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mussetti, Alberto Salas, Maria Queralt Condom, Maria Antonio, Maite Ochoa, Cristian Ivan, Iulia Jimenez Ruiz-De la Torre, David Sanz Linares, Gabriela Ansoleaga, Belen Patiño-Gutierrez, Beatriz Jimenez-Prat, Laura Parody, Rocio Sureda-Balari, Ana |
spellingShingle |
Mussetti, Alberto Salas, Maria Queralt Condom, Maria Antonio, Maite Ochoa, Cristian Ivan, Iulia Jimenez Ruiz-De la Torre, David Sanz Linares, Gabriela Ansoleaga, Belen Patiño-Gutierrez, Beatriz Jimenez-Prat, Laura Parody, Rocio Sureda-Balari, Ana Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study JMIR Formative Research |
author_facet |
Mussetti, Alberto Salas, Maria Queralt Condom, Maria Antonio, Maite Ochoa, Cristian Ivan, Iulia Jimenez Ruiz-De la Torre, David Sanz Linares, Gabriela Ansoleaga, Belen Patiño-Gutierrez, Beatriz Jimenez-Prat, Laura Parody, Rocio Sureda-Balari, Ana |
author_sort |
Mussetti, Alberto |
title |
Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study |
title_short |
Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study |
title_full |
Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study |
title_fullStr |
Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study |
title_full_unstemmed |
Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study |
title_sort |
use of telehealth for domiciliary follow-up after hematopoietic cell transplantation during the covid-19 pandemic: prospective pilot study |
publisher |
JMIR Publications |
series |
JMIR Formative Research |
issn |
2561-326X |
publishDate |
2021-03-01 |
description |
BackgroundPatients who have recently received a hematopoietic cell transplant (HCT) are at higher risk of acute complications in the first weeks after discharge, especially during the COVID-19 pandemic.
ObjectiveThe aim of this study was to test the use of a telehealth platform for the follow-up of HCT patients during the first two weeks after discharge.
MethodsIn total, 21 patients who received autologous or allogeneic HCT for hematological malignancies were screened from April 30, 2020, to July 15, 2020. The telehealth platform assisted in the daily collection of vital signs as well as physical and psychological symptoms for two weeks after hospital discharge. The required medical devices (oximeter and blood pressure monitor) were given to patients and a dedicated smartphone app was developed to collect this data. The data were reviewed daily through web-based software by a hematologist specializing in HCT.
ResultsOnly 12 of 21 patients were able to join and complete the study. Technological barriers were the most frequent limiting factor in this study. Among the 12 patients who completed the study, adherence to data reporting was high. The patients’ experience of using such a system was considered good. In two cases, the system enabled the early recognition of acute complications.
ConclusionsThis pilot study showed that telehealth systems can be applied in the early posttransplant setting, with evident advantages for physicians and patients for both medical and psychological aspects. Technological issues still represent a challenge for the applicability of such a system, especially for older adult patients. Easier-to-use technologies could help to expand the use of telehealth systems in this setting in the future. |
url |
https://formative.jmir.org/2021/3/e26121 |
work_keys_str_mv |
AT mussettialberto useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy AT salasmariaqueralt useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy AT condommaria useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy AT antoniomaite useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy AT ochoacristian useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy AT ivaniulia useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy AT jimenezruizdelatorredavid useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy AT sanzlinaresgabriela useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy AT ansoleagabelen useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy AT patinogutierrezbeatriz useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy AT jimenezpratlaura useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy AT parodyrocio useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy AT suredabalariana useoftelehealthfordomiciliaryfollowupafterhematopoieticcelltransplantationduringthecovid19pandemicprospectivepilotstudy |
_version_ |
1721546224989896704 |